These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26827115)

  • 41. Genetic and biochemical pathways of beta-cell failure in type 2 diabetes.
    Talchai C; Lin HV; Kitamura T; Accili D
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():38-45. PubMed ID: 19817787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stress-induced adaptive islet cell identity changes.
    Cigliola V; Thorel F; Chera S; Herrera PL
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):87-96. PubMed ID: 27615136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes.
    Weir GC; Marselli L; Marchetti P; Katsuta H; Jung MH; Bonner-Weir S
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():82-90. PubMed ID: 19817791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta cell mass in diabetes: a realistic therapeutic target?
    Meier JJ
    Diabetologia; 2008 May; 51(5):703-13. PubMed ID: 18317728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment.
    Marchetti P; Dotta F; Lauro D; Purrello F
    Regul Pept; 2008 Feb; 146(1-3):4-11. PubMed ID: 17889380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lineage Reprogramming: A Promising Road for Pancreatic β Cell Regeneration.
    Wei R; Hong T
    Trends Endocrinol Metab; 2016 Mar; 27(3):163-176. PubMed ID: 26811208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The rise and fall of insulin secretion in type 1 diabetes mellitus.
    Tsai EB; Sherry NA; Palmer JP; Herold KC
    Diabetologia; 2006 Feb; 49(2):261-70. PubMed ID: 16404554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bringing the human pancreas into focus: new paradigms for the understanding of Type 1 diabetes.
    Morgan NG
    Diabet Med; 2017 Jul; 34(7):879-886. PubMed ID: 28429491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biphasic decline of β-cell function with age in euglycemic nonobese diabetic mice parallels diabetes onset.
    Cechin SR; Lopez-Ocejo O; Karpinsky-Semper D; Buchwald P
    IUBMB Life; 2015 Aug; 67(8):634-44. PubMed ID: 26099053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The triumvirate of beta-cell regeneration: solutions and bottlenecks to curing diabetes.
    Singh SP; Ninov N
    Int J Dev Biol; 2018; 62(6-7-8):453-464. PubMed ID: 29938757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A shared comparison of diabetes mellitus and neurodegenerative disorders.
    Morsi M; Maher A; Aboelmagd O; Johar D; Bernstein L
    J Cell Biochem; 2018 Feb; 119(2):1249-1256. PubMed ID: 28681964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
    Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs and the functional β cell mass: For better or worse.
    Guay C; Regazzi R
    Diabetes Metab; 2015 Nov; 41(5):369-77. PubMed ID: 25910875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-cell mass and type 1 diabetes: going, going, gone?
    Akirav E; Kushner JA; Herold KC
    Diabetes; 2008 Nov; 57(11):2883-8. PubMed ID: 18971435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
    Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
    J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes.
    Roche E; Reig JA; Campos A; Paredes B; Isaac JR; Lim S; Calne RY; Soria B
    Transpl Immunol; 2005 Dec; 15(2):113-29. PubMed ID: 16412956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.